Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

FDA approves COVID-19 treatment for those under the age of 12

Veklury is currently the only COVID-19 treatment approved for this age group

- PMLiVE

Cancer Research UK drives innovation with Cancer Research Horizons

Industry partners will gain access to an extensive network of 4,000 world-leading cancer researchers

- PMLiVE

Gilead’s Veklury significant decreases risk of hospitalisation for COVID-19 patients

Using Veklury within five days of symptom onset – or between five to seven days of symptom onset – reduced hospitalisations in patients at high risk for severe COVID-19 disease

- PMLiVE

Biogen retracts EMA application for Alzheimer’s drug Aduhelm

The application was pulled after the CHMP said the data provided was not enough to support a marketing authorisation

- PMLiVE

Novartis UK launches local charity partnerships to support social mobility pledges

The company has partnered with the Social Mobility Foundation, Founders4Schools and OnSide

- PMLiVE

Lessons from a pandemic – holistic strategy in the time of coronavirus

COVID-19 has delivered a scenario where developing the strategy for any brand is a challenge

- PMLiVE

Is there such a thing as the new normal? Or is it simply the ‘here and now’?

By Chris Grimes-Crompton

The decentralisation of clinical trials is a key catalyst for innovation in artificial intelligence

By Michael Phillips

- PMLiVE

The great reset of frontline HCP relationships

By Madelaine Allen

- PMLiVE

Equipping our people leaders to drive an inclusive organisation

By Mary O’Reilly (pictured) and Nikki O’Hanlon

- PMLiVE

Listen, learn and lift off

By Danny Buckland

- PMLiVE

Virtually present: how to hear every voice in a hybrid setting

By Shaun Beedle

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links